The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor mutation burden in triple negative breast cancer patients in Japan.
 
Masayuki Nagahashi
Research Funding - Denka Co., Ltd (Inst)
 
Yiwei Ling
No Relationships to Disclose
 
Tetsu Hayashida
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Novartis; Takeda
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Taiho Pharmaceutical (Inst)
 
Yuko Kitagawa
Honoraria - Asahi Kasei; Chugai Pharma; Ethicon; Nippon Kayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ajinomoto (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); CSL Behring (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); EA Pharma (Inst); GlaxoSmithKline (Inst); Kaken Pharmaceutical (Inst); Kowa (Inst); Kureha (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Medicon (Inst); Medtronic (Inst); Merck Serono (Inst); Nippon Kayaku (Inst); Novartis (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Taisho Toyama Pharma (Inst); Takeda (Inst); Teijin Pharma (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
 
Manabu Futamura
No Relationships to Disclose
 
Kazuhiro Yoshida
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Covidien; Daiichi Sankyo; Denka Co., Ltd; EA Pharma; Eisai; Johnson & Johnson; Lilly; Merck Serono; MSD K.K; Nippon Kayaku; Olympus; Ono Pharmaceutical; Otsuka; Sanofi; Taiho Pharmaceutical; Takeda; TERUMO; Yakult Honsha
Research Funding - Abbott (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Johnson & Johnson (Inst); KCI (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Toyama Chemical Co (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
Travel, Accommodations, Expenses - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Covidien; Daiichi Sankyo; Denka Co., Ltd; EA Pharma; Eisai; Johnson & Johnson; Lilly; Merck Serono; MSD K.K; MSD K.K; Nippon Kayaku; Olympus; Ono Pharmaceutical; Otsuka; Sanofi; Taiho Pharmaceutical; Takeda; TERUMO; Yakult Honsha
 
Takashi Kuwayama
No Relationships to Disclose
 
Seigo Nakamura
Honoraria - AstraZeneca; Chugai Pharma; Pfizer; Taiho Pharmaceutical
 
Chie Toshikawa
No Relationships to Disclose
 
Hideko Yamauchi
Honoraria - Aragan Japan; AstraZeneca; Chugai Pharma; Elsevier Japan; Novartis; Pfizer; Shionogi; Taiho Pharmaceutical; TOWA
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Teruo Yamauchi
Honoraria - AstraZeneca (I); Chugai Pharma (I); Elsevier (I); Novartis (I); Pfizer (I); Shionogi (I); Taiho Pharmaceutical (I)
Consulting or Advisory Role - AstraZeneca (I)
 
Koji Kaneko
No Relationships to Disclose
 
Chizuko Kanbayashi
No Relationships to Disclose
 
Nobuaki Sato
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Pfizer; Taiho Pharmaceutical
 
Yasuo Miyoshi
Speakers' Bureau - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Junko Tsuchida
No Relationships to Disclose
 
Stephen Lyle
Employment - KEW
Stock and Other Ownership Interests - KEW
Consulting or Advisory Role - Pfizer
 
Kazuaki Takabe
No Relationships to Disclose
 
Shujiro Okuda
No Relationships to Disclose
 
Toshifumi Wakai
No Relationships to Disclose